Clinical features of 405 Japanese patients with systemic sclerosis

Modern Rheumatology

Volumn 22, Issue 2, 2012, Pages 272-279

  Hashimoto, Atsushi ^a   Endo, Hirahito ^b   Kondo, Hirobumi ^a   Hirohata, Shunsei ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antibody; Scleroderma; Scleroderma renal crisis; Sj gren's syndrome; Systemic sclerosis

Indexed keywords

ANTI U1 RNP ANTIBODY; AUTOANTIBODY; CENTROMERE ANTIBODY; SCL 70 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

AUTOANTIBODIES; BIOLOGICAL MARKERS; CENTROMERE; COHORT STUDIES; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; NUCLEAR PROTEINS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; SEX FACTORS; SKIN DISEASES;

EID: 84861481021     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-011-0515-7     Document Type: Article

References (35)

1. Silver RM, Medsger TA Jr, Bolster MB. Systemic sclerosis and scleroderma variants: clinical aspects. In: Koopman WJ, Moreland LW, editors. Arthritis and Allied Conditions: a textbook of rheumatology. 15th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 1633-80.
2. Steen VD, Ziegler GL, Rodnan GP, Medsger TA Jr. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum. 1984;27: 125-31. (Pubitemid 14191016)
3. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum. 2005;35:35-42. (Pubitemid 41111469)
4. Steen VD, Powell DL, Medsger TA Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum. 1988;31:196-203. (Pubitemid 18088039)
5. Kuwana M, Kaburaki J, Arnett FC, Howard RF, Medsger TA Jr, Wright TM. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti- DNA topoisomerase I antibody. Arthritis Rheum. 1999;42: 465-74. (Pubitemid 29136094)
6. Barnett AJ, Coventry DA. Scleroderma. 1. Clinical features, course of illness and response to treatment in 61 cases. Med J Aust. 1969;1:992-1001.
7. Hashimoto A, Tejima S, Tono T, Suzuki M, Tanaka S, Matsui T, et al. Predictors of survival and causes of death in Japanese patients with systemic sclerosis. J Rheumatol. 2011 [Epub ahead of print].
8. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581-90.
9. Ihn H. Systemic sclerosis (in Japanese). Jpn J Dermatol. 2006; 116:413-9.
10. Barnett AJ, Miller MH, Littlejohn GO. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol. 1988;15:276-83. (Pubitemid 18073752)
11. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281-5.
12. Domsic R, Fasanella K, Bielefeldt K. Gastrointestinal manifestations of systemic sclerosis. Dig Dis Sci. 2008;53:1163-74. (Pubitemid 351514626)
13. Steen VD, Medsger TA Jr, Osial TA Jr, Ziegler GL, Shapiro AP, Rodnan GP. Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med. 1984;76:779-86. (Pubitemid 14142675)
14. Denolin H. Diagnosis of pulmonary hypertension by direct measurement. In: Hatano S, Strasser T, editors. Report on a WHO Meeting: primary pulmonary hypertension. Geneva: World Health Organization; 1975. p. 40-5.
15. Schachna L, Wigley FM, Chang B, White B, Wise RA, Gelber AC. Age and risk of pulmonary arterial hypertension in scleroderma. Chest. 2003;124:2098-104. (Pubitemid 38010575)
16. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-7. (Pubitemid 13221242)
17. Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24. (Pubitemid 18091653)
18. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjögren syndrome (1999): availability and validity. Mod Rheumatol. 2004;14:425-34. (Pubitemid 40028665)
19. Hamaguchi Y, Hasegawa M, Fujimoto M, Matsushita T, Komura K, Kaji K, et al. The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol. 2008;158:487-95. (Pubitemid 351239185)
20. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med. 2005;118:2-10. (Pubitemid 40082450)
21. Tamaki T, Mori S, Takehara K. Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res. 1991;283: 366-71.
22. Feghali-Bostwick C, Medsger TA Jr, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum. 2003;48:1956-63. (Pubitemid 36828691)
23. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003;48:2246-55. (Pubitemid 36959206)
24. Lee P, Langevitz P, Alderdice CA, Aubrey M, Baer PA, Baron M, et al. Mortality in systemic sclerosis (scleroderma). Q J Med. 1992;82:139-48.
25. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000;43: 2437-44.
26. Medsger TA Jr. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am. 2003; 29:255-73.
27. Steen VD. Scleroderma renal crisis. Rheum Dis Clin North Am. 2003;29:315-33. (Pubitemid 36765123)
28. Kondo H, Yanagida K, Uchida K, Kashiwazaki S. Renal involvement in progressive systemic sclerosis (PSS) (in Japanese). Ryumachi. 1982;22:293-300.
29. Kashiwazaki S. Scleroderma renal crisis (in Japanese). Ryumachi. 1986;26:126-33.
30. van den Born BJ, Koopmans RP, Groeneveld JO, van Montfrans GA. Ethnic disparities in the incidence, presentation and complications of malignant hypertension. J Hypertens. 2006;24: 2299-304. (Pubitemid 44611041)
31. Ferri C, Bernini L, Cecchetti R, Latorraca A, Marotta G, Pasero G, et al. Cutaneous and serologic subsets of systemic sclerosis. J Rheumatol. 1991;18:1826-32.
32. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum. 1994;37:75-83. (Pubitemid 24027696)
33. Nimelstein SH, Brody S, McShane D, Holman HR. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine (Baltimore). 1980;59:239-48. (Pubitemid 10093114)
34. Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999;42:899-909. (Pubitemid 29215000)
35. Osial TA Jr, Whiteside TL, Buckingham RB, Singh G, Barnes EL, Pierce JM, et al. Clinical and serologic study of Sjogren's syndrome in patients with progressive systemic sclerosis. Arthritis Rheum. 1983;26:500-8. (Pubitemid 13120239)